Skip to content

NGEN

NervGen Pharma Corp.

NASDAQ · Healthcare · Biotechnology · CA

$2.05
−9.69%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 12, 2026
EPS estimate
-$0.10
Revenue estimate

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$0.37
EPS estimate
-$0.06
Revenue actual
Revenue estimate
$4.5K

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
-198.5%
Revenue beats (12Q)

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$13
PT range
$10 – $15
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$0.06-$0.37Miss -510.76%
May 18, 2026-$0.07-$0.01Beat 80.35%
Mar 31, 2026-$0.10-$0.26Miss -165.12%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026